Contingency Management for Stimulant Use Disorder (MIMIC2 Trial)

N/A

Waitlist Available

Led By Sara Becker

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will evaluate a multi-level implementation strategy to install contingency management for stimulant use in 10 public opioid treatment programs. It will measure outcomes, provide staff feedback & rigorously evaluate its effectiveness.

Who is the study for?

This trial is for adults who are currently receiving medication for opioid use disorders within the last 30 days and also use stimulants, as shown by self-report or positive tests. They must be actively managing patient cases and providing psychosocial support. It's not open to those under 18, unable to consent, or without electronic medical records.

What is being tested?

The study is testing a strategy called Science of Service Laboratory designed to help opioid treatment programs implement contingency management for patients with stimulant use disorder. The effectiveness of this multi-level approach will be measured in terms of its adoption by staff and impact on patient outcomes.

What are the potential side effects?

Since this trial focuses on implementing a service strategy rather than a drug, it does not have traditional side effects. However, there may be challenges related to adapting new practices that could affect staff performance and patient care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in percent of counselors delivering contingency management from pre-implementation to post-implementation

Change in percent of patients receiving contingency management from pre-implementation to post-implementation

Secondary study objectives

Change in number of contingency management sessions

Change in the percent of toxicology screens negative for stimulants

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Science of Service Laboratory implementation strategyExperimental Treatment1 Intervention

The Science of Service Laboratory implementation strategy consists of: didactic training (contingency management workshops; monthly contingency management coaching calls), performance feedback (practice sessions and electronic medical record feedback); and facilitation (monthly facilitation calls).

Group II: Stepped wedge comparatorActive Control1 Intervention

Our hybrid trial uses a unidirectional crossover stepped wedge design. All sites cross over in the same direction from usual care to intervention. All sites therefore act as their own comparison prior to the sequential roll-out of the implementation strategy.

Do I qualify?Apply below to find out